Gallego O - Search Results

1

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.

Gallego O, de Mendoza C, Pérez-Elías MJ, Guardiola JM, Pedreira J, Dalmau D, Gónzalez J, Moreno A, Arribas JR, Rubio A, García-Arata I, Leal M, Domingo P, Soriano V. Gallego O, et al. AIDS. 2001 Sep 7;15(13):1701-6. doi: 10.1097/00002030-200109070-00014. AIDS. 2001. PMID: 11546946

2

Mechanisms of resistance to antiretroviral drugs--clinical implications.

de Mendoza C, Gallego O, Soriano V. de Mendoza C, et al. Among authors: gallego o. AIDS Rev. 2002 Apr-Jun;4(2):64-82. AIDS Rev. 2002. PMID: 12152520 Review.

3

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

Gallego O, Corral A, de Mendoza C, Rodés B, Soriano V. Gallego O, et al. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):857-60. doi: 10.1089/08892220260190335. AIDS Res Hum Retroviruses. 2002. PMID: 12201908

4

Rate of virological treatment failure and frequencies of drug resistance genotypes among human immunodeficiency virus-positive subjects on antiretroviral therapy in Spain.

Gallego O, Ruíz L, Vallejo A, Clotet B, Leal M, Soriano V. Gallego O, et al. J Clin Microbiol. 2002 Oct;40(10):3865-6. doi: 10.1128/JCM.40.10.3865-3866.2002. J Clin Microbiol. 2002. PMID: 12354903 Free PMC article.

5

Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.

Gallego O, de Mendoza C, Corral A, Soriano V. Gallego O, et al. AIDS. 2003 Apr 11;17(6):919-21. doi: 10.1097/00002030-200304110-00020. AIDS. 2003. PMID: 12660542 No abstract available.

6

Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.

González de Requena D, Gallego O, de Mendoza C, Corral A, Jiménez-Nácher I, Soriano V. González de Requena D, et al. Among authors: gallego o. AIDS Res Hum Retroviruses. 2003 Jun;19(6):457-9. doi: 10.1089/088922203766774496. AIDS Res Hum Retroviruses. 2003. PMID: 12882654

7

Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues.

Gallego O, de Mendoza C, Corral A, Soriano V. Gallego O, et al. AIDS. 2004 Mar 5;18(4):689-90. doi: 10.1097/00002030-200403050-00014. AIDS. 2004. PMID: 15090775 No abstract available.

8

Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations.

González de Requena D, Gallego O, Corral A, Jiménez-Nácher I, Soriano V. González de Requena D, et al. Among authors: gallego o. AIDS. 2004 Oct 21;18(15):2091-4. doi: 10.1097/00002030-200410210-00017. AIDS. 2004. PMID: 15577634

9

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

Gallego O, Ruiz L, Vallejo A, Ferrer E, Rubio A, Clotet B, Leal M, Soriano V; ERASE-3 Group. Gallego O, et al. AIDS. 2001 Sep 28;15(14):1894-6. doi: 10.1097/00002030-200109280-00025. AIDS. 2001. PMID: 11579258

10

Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.

de Mendoza C, Martín-Carbonero L, Barreiro P, Diaz B, Valencia E, Jiménez-Nácher I, Gallego O, Núñez M, González-Lahoz J, Soriano V. de Mendoza C, et al. Among authors: gallego o. HIV Clin Trials. 2002 Jul-Aug;3(4):304-9. doi: 10.1310/h5jn-mfg3-g35k-qx9j. HIV Clin Trials. 2002. PMID: 12187504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters